Researchers at the University of Pittsburgh have devised a biomarker test that can spot small amounts of clumping tau protein ...

Up to half of all people living with Alzheimer's Disease in Ireland remain undiagnosed. Now, a new blood test may have the ...

Alzheimer's disease, a type of dementia that profoundly alters a person’s memory and cognitive function, affects an estimated ...

Progressive and incurable, Alzheimer’s disease affects an estimated 6.7 million U.S. adults at least 65 years old, according ...

Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...

New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.

A new study led by researchers at Mass General Brigham suggests that different brain regions activated by creative tasks are ...

A new study published in the Archives of Gerontology and Geriatrics suggests that the way the brain processes language and ...

Many people use the terms Alzheimer’s disease and dementia as if they mean the same thing, but they actually refer to ...

Alzheimer’s disease is the most common ... “We usually recommend doing an imaging study of the brain, such as an MRI [magnetic resonance imaging] or a CT [computed tomography] scan. We're looking to ...

The study found structural changes in the gut of Alzheimer’s-affected mice, revealing abnormalities in intestinal cells, neurons, and mucus secretion. This supports the hypothesis that harmful gut ...